ATE236932T1 - Dna kodierend für prostaglandin rezeptor ip - Google Patents

Dna kodierend für prostaglandin rezeptor ip

Info

Publication number
ATE236932T1
ATE236932T1 AT94928741T AT94928741T ATE236932T1 AT E236932 T1 ATE236932 T1 AT E236932T1 AT 94928741 T AT94928741 T AT 94928741T AT 94928741 T AT94928741 T AT 94928741T AT E236932 T1 ATE236932 T1 AT E236932T1
Authority
AT
Austria
Prior art keywords
prostaglandin receptor
receptor
dna coding
host cells
dna encoding
Prior art date
Application number
AT94928741T
Other languages
English (en)
Inventor
Mark Abramovitz
Yves Boie
Richard Grygorczyk
Kathleen Metters
Thomas H Rushmore
Deborah M Slipetz
Original Assignee
Merck Frosst Canada Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=22461361&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ATE236932(T1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Merck Frosst Canada Inc filed Critical Merck Frosst Canada Inc
Application granted granted Critical
Publication of ATE236932T1 publication Critical patent/ATE236932T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C07K14/72—Receptors; Cell surface antigens; Cell surface determinants for hormones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Zoology (AREA)
  • Molecular Biology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Toxicology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Cell Biology (AREA)
  • Endocrinology (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AT94928741T 1993-10-06 1994-10-03 Dna kodierend für prostaglandin rezeptor ip ATE236932T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US08/134,012 US5516652A (en) 1993-10-06 1993-10-06 DNA encoding prostaglandin receptor IP
PCT/CA1994/000548 WO1995009872A1 (en) 1993-10-06 1994-10-03 Dna encoding prostaglandin receptor ip

Publications (1)

Publication Number Publication Date
ATE236932T1 true ATE236932T1 (de) 2003-04-15

Family

ID=22461361

Family Applications (1)

Application Number Title Priority Date Filing Date
AT94928741T ATE236932T1 (de) 1993-10-06 1994-10-03 Dna kodierend für prostaglandin rezeptor ip

Country Status (8)

Country Link
US (3) US5516652A (de)
EP (1) EP0722462B1 (de)
JP (1) JP3029125B2 (de)
AT (1) ATE236932T1 (de)
CA (1) CA2173595C (de)
DE (1) DE69432470T2 (de)
ES (1) ES2192561T3 (de)
WO (1) WO1995009872A1 (de)

Families Citing this family (29)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2183063A1 (en) * 1994-02-10 1995-08-17 Atsushi Ichikawa Prostaglandin i2 receptor
US6395878B1 (en) * 1994-05-05 2002-05-28 Allergan Sales, Inc. Nucleic acid encoding a human EP prostaglandin receptor
JP3064015B2 (ja) 1995-01-26 2000-07-12 メルク フロスト カナダ アンド カンパニー プロスタグランジンレセプターｄｐ
CA2364948C (en) 1999-03-05 2011-04-26 Duke University C16 unsaturated fp-selective prostaglandins analogs
US6894175B1 (en) * 1999-08-04 2005-05-17 The Procter & Gamble Company 2-Decarboxy-2-phosphinico prostaglandin derivatives and methods for their preparation and use
US20020172693A1 (en) 2000-03-31 2002-11-21 Delong Michell Anthony Compositions and methods for treating hair loss using non-naturally occurring prostaglandins
US20020037914A1 (en) * 2000-03-31 2002-03-28 Delong Mitchell Anthony Compositions and methods for treating hair loss using C16-C20 aromatic tetrahydro prostaglandins
US20020013294A1 (en) 2000-03-31 2002-01-31 Delong Mitchell Anthony Cosmetic and pharmaceutical compositions and methods using 2-decarboxy-2-phosphinico derivatives
US20020146439A1 (en) * 2000-03-31 2002-10-10 Delong Mitchell Anthony Compositions and methods for treating hair loss using oximyl and hydroxylamino prostaglandins
US6673760B1 (en) * 2000-06-29 2004-01-06 Ecolab Inc. Rinse agent composition and method for rinsing a substrate surface
US20040253668A1 (en) * 2002-01-22 2004-12-16 Ramanathan Chandra S. Novel G-protein coupled receptor (GPCR) variants and methods of use thereof
DE10229872A1 (de) * 2002-07-03 2004-01-29 Curevac Gmbh Immunstimulation durch chemisch modifizierte RNA
WO2004071508A1 (en) * 2003-02-14 2004-08-26 Medical Research Council Ip receptor antagonists for the treatment of pathological uterine conditions
DE102006035618A1 (de) * 2006-07-31 2008-02-07 Curevac Gmbh Nukleinsäure der Formel (I): GlXmGn, insbesondere als immunstimulierendes Adjuvanz
JP2010507361A (ja) 2006-07-31 2010-03-11 キュアバック ゲーエムベーハー 具体的には免疫刺激剤／アジュバントとしての、一般式（Ｉ）：ＧｌＸｍＧｎ、または一般式（ＩＩ）：ＣｌＸｍＣｎで表される核酸
WO2009030254A1 (en) 2007-09-04 2009-03-12 Curevac Gmbh Complexes of rna and cationic peptides for transfection and for immunostimulation
CN101932707B (zh) 2008-01-31 2013-08-21 库瑞瓦格有限责任公司 作为免疫刺激剂/佐剂的式(I)(NuGlXmGnNv)a的核酸及其衍生物
WO2010037408A1 (en) 2008-09-30 2010-04-08 Curevac Gmbh Composition comprising a complexed (m)rna and a naked mrna for providing or enhancing an immunostimulatory response in a mammal and uses thereof
US8623918B2 (en) * 2008-10-29 2014-01-07 Novaer Holdings, Inc. Amino acid salts of prostaglandins
US8722739B2 (en) 2008-10-29 2014-05-13 Novaer Holdings, Inc. Amino acid salts of prostaglandins
US20110053829A1 (en) 2009-09-03 2011-03-03 Curevac Gmbh Disulfide-linked polyethyleneglycol/peptide conjugates for the transfection of nucleic acids
WO2011159904A1 (en) * 2010-06-17 2011-12-22 The Trustees Of The University Of Pennsylvania Methods for predicting cellular signaling responses to combinatorial stimuli
RS55856B1 (sr) 2010-07-14 2017-08-31 Novartis Ag Heterociklična jedinjenja agonisti ip receptora
US8968746B2 (en) 2010-07-30 2015-03-03 Curevac Gmbh Complexation of nucleic acids with disulfide-crosslinked cationic components for transfection and immunostimulation
CN104053659B (zh) 2012-01-13 2016-11-09 诺华股份有限公司 用于治疗肺动脉高压(pah)及相关病症的作为ip 受体激动剂的稠合的吡咯类
WO2013113326A1 (en) 2012-01-31 2013-08-08 Curevac Gmbh Pharmaceutical composition comprising a polymeric carrier cargo complex and at least one protein or peptide antigen
EP2956455B1 (de) 2013-02-13 2017-05-17 Novartis AG Als ip-rezeptor-agonisten wirkende heterocyclische verbindungen
CA2915728A1 (en) 2013-08-21 2015-02-26 Thomas Kramps Respiratory syncytial virus (rsv) vaccine
CA2936286A1 (en) 2014-04-01 2015-10-08 Curevac Ag Polymeric carrier cargo complex for use as an immunostimulating agent or as an adjuvant

Also Published As

Publication number Publication date
DE69432470D1 (de) 2003-05-15
US6365360B1 (en) 2002-04-02
US5516652A (en) 1996-05-14
CA2173595C (en) 2001-06-12
US5728808A (en) 1998-03-17
EP0722462A1 (de) 1996-07-24
JP3029125B2 (ja) 2000-04-04
JPH09503213A (ja) 1997-03-31
EP0722462B1 (de) 2003-04-09
WO1995009872A1 (en) 1995-04-13
ES2192561T3 (es) 2003-10-16
CA2173595A1 (en) 1995-04-13
DE69432470T2 (de) 2004-01-29

Similar Documents

Publication Publication Date Title
DE69432470T2 (de) Dna kodierend für prostaglandin rezeptor ip
ATE170532T1 (de) Prostaglandin rezeptor fp und kodierende dns
CA2170509A1 (en) Dna encoding prostaglandin receptor ep2
ES2153037T3 (es) Lacasas purificadas de scytalidium y acidos nucleicos que las codifican.
ATE157398T1 (de) Prostaglandinrezeptor ep1 kodierende dna
WO1996023066A3 (en) Prostaglandin receptor, dp
PT765394E (pt) Lacases myceliophthora purificadas e acidos nucleicos que as codificam
AU2827895A (en) Purified polyporus laccases and nucleic acids encoding same
DE69836088D1 (de) Als lerk6 bezeichnetes cytokin
DE3789273D1 (de) Kodierungssystem zur Reduktion der Redundanz.
DE69738586D1 (de) Hohe expressionsrate von proteinen
PT101297A (pt) Factores mitogenicos gliais, sua preparacao e utilizacao
DE69939982D1 (de) B7l-1 moleküle
WO1995009872B1 (en) Dna encoding prostaglandin receptor ip
DE69426033D1 (de) Für die alpha-1e untereinheit des menschlichen kalziumkanals kodierende dna
ATE172471T1 (de) Prostaglandin rezeptor ep3 und kodierende dns
EP0785716A4 (de) Als lerk6 bezeichnetes cytokin
AR001014A1 (es) Una molecula de dna aislada que codifica daunorubicina 14-hidroxilasa, dicha daunorubicina 14-hidroxilasa, procedimiento para producir dicho dna,vector que comprende dicho dna, celula huesped que contiene dicho vector, procedimiento para producir doxorubicina mediante dicha celula
NO905545D0 (no) Renset ubiquitinhydrolase, dna-sekvenser som koder for samme, samt anvendelse for isolering av polypeptider.

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties